23009-01-0Relevant articles and documents
Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives useful in the treatment of allergic conditions
-
, (2008/06/13)
A method of treating allergic disorders and pharmaceutical compositions therefore are disclosed for a series of 5-[(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives of Formula I. These compounds are useful in inhibiting Type I allergic STR1 responses in a living animal and thus can be used to treat allergic phenomena such as asthma, rhinitis, atopic dermatitis, chronic hives, allergic conjunctivitis and the like.
METHOD OF TREATING ANXIETY WITH 5-[(4-ARYL OR HETEROARYL-1-PIPERAZINYL)ALKYL]-2-OXAZOLIDINONES
-
, (2008/06/13)
This invention discloses the antianxiety properties of compounds of the formula: STR1 wherein n is 3 or 4, R is C 1-C. sub.4 alkyl or phenyl, and Ar is STR2 where Z is selected from H, C. sub.1-C 4 alkoxy, C 2-C 4 alkenyloxy or hydroxy.